JP2022501370A5 - - Google Patents
Info
- Publication number
- JP2022501370A5 JP2022501370A5 JP2021515492A JP2021515492A JP2022501370A5 JP 2022501370 A5 JP2022501370 A5 JP 2022501370A5 JP 2021515492 A JP2021515492 A JP 2021515492A JP 2021515492 A JP2021515492 A JP 2021515492A JP 2022501370 A5 JP2022501370 A5 JP 2022501370A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- hydrogen
- cycloalkyl
- group
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862733692P | 2018-09-20 | 2018-09-20 | |
| US62/733,692 | 2018-09-20 | ||
| PCT/IB2019/057814 WO2020058844A1 (en) | 2018-09-20 | 2019-09-17 | Inhibitors of human immunodeficiency virus replication |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022501370A JP2022501370A (ja) | 2022-01-06 |
| JPWO2020058844A5 JPWO2020058844A5 (https=) | 2022-09-05 |
| JP2022501370A5 true JP2022501370A5 (https=) | 2022-09-05 |
| JP7433303B2 JP7433303B2 (ja) | 2024-02-19 |
Family
ID=68000004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021515492A Active JP7433303B2 (ja) | 2018-09-20 | 2019-09-17 | ヒト免疫不全ウイルス複製の阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11919897B2 (https=) |
| EP (1) | EP3853228A1 (https=) |
| JP (1) | JP7433303B2 (https=) |
| WO (1) | WO2020058844A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021004593A (es) | 2018-10-24 | 2021-06-15 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. |
| US20210395262A1 (en) * | 2018-10-24 | 2021-12-23 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| EP3873607B1 (en) * | 2018-10-29 | 2023-11-29 | VIIV Healthcare UK (No.5) Limited | Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus replication |
| SG11202107145SA (en) | 2019-01-25 | 2021-08-30 | Univ Brown | Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders |
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| TWI902729B (zh) | 2019-11-28 | 2025-11-01 | 日商鹽野義製藥股份有限公司 | 以組合整合酶阻礙劑及抗ｈｉｖ藥為特徵之ｈｉｖ感染症的預防及治療用醫藥 |
| KR20220151655A (ko) * | 2020-03-06 | 2022-11-15 | 비브 헬스케어 유케이 (넘버5) 리미티드 | 인간 면역결핍 바이러스 복제의 억제제 |
| CN115397424A (zh) * | 2020-04-15 | 2022-11-25 | Viiv保健英国第五有限公司 | 人类免疫缺陷病毒复制的抑制剂 |
| US20250042926A1 (en) * | 2023-05-31 | 2025-02-06 | Gilead Sciences, Inc. | Therapeutic compounds for hiv |
| AR132951A1 (es) | 2023-06-15 | 2025-08-13 | Viiv Healthcare Uk No 5 Ltd | Métodos e intermedios para preparar compuestos |
| US12594276B2 (en) | 2024-02-05 | 2026-04-07 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2612585A1 (en) | 2005-06-27 | 2007-01-04 | Amgen Inc. | Anti-inflammatory aryl nitrile compounds |
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| EP2729448B1 (en) | 2011-07-06 | 2015-09-09 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| CA2897268C (en) | 2013-01-09 | 2018-12-04 | Gilead Sciences, Inc. | Therapeutic compounds for the treatment of viral infections |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| CA2896244C (en) | 2013-01-09 | 2017-07-04 | Gilead Sciences, Inc. | 5-membered heteroaryls and their use as antiviral agents |
| TWI694071B (zh) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| WO2015130964A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Therapeutic compounds |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| PT3186239T (pt) | 2014-08-29 | 2019-01-10 | Gilead Sciences Inc | Agentes antirretrovirais |
| KR20230011471A (ko) | 2016-08-19 | 2023-01-20 | 길리애드 사이언시즈, 인코포레이티드 | Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물 |
| TW201906834A (zh) | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| US10836746B2 (en) | 2018-02-15 | 2020-11-17 | Gilead Sciences, Inc. | Therapeutic compounds |
| WO2019161280A1 (en) | 2018-02-16 | 2019-08-22 | Gilead Sciences, Inc. | Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection |
-
2019
- 2019-09-17 JP JP2021515492A patent/JP7433303B2/ja active Active
- 2019-09-17 US US17/273,748 patent/US11919897B2/en active Active
- 2019-09-17 WO PCT/IB2019/057814 patent/WO2020058844A1/en not_active Ceased
- 2019-09-17 EP EP19773190.4A patent/EP3853228A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022501370A5 (https=) | ||
| JP2022500425A5 (https=) | ||
| IL268282B2 (en) | hiv inhibitory compounds | |
| JP2016527217A5 (https=) | ||
| JP2013209405A5 (https=) | ||
| JP2019500387A5 (https=) | ||
| JP2021514373A5 (https=) | ||
| IL275762B1 (en) | Derivatives of phenyl-so2-nh-c(=o)-phenyl-piperazine-ch2-1,2-cyclohexane-bicyclo[1.1.1]pentane and pharmaceutical compositions comprising them | |
| JP2019528280A5 (https=) | ||
| JPWO2023099608A5 (https=) | ||
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| JP2024173998A5 (https=) | ||
| JP2014037426A5 (https=) | ||
| JP2016510038A5 (https=) | ||
| JP2017537949A5 (https=) | ||
| JP2016518437A5 (https=) | ||
| HRP20240501T1 (hr) | Derivati pirido[2,3-d]pirimidina kao inhibitori replikacije virusa humane imunodeficijencije | |
| JP2019511542A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| JP2016516773A5 (https=) | ||
| RU2015110699A (ru) | Фармацевтическая антиретровирусная композиция | |
| JP2021535112A5 (https=) | ||
| JPWO2020058844A5 (https=) | ||
| JP2021530513A5 (https=) | ||
| JP2018522861A5 (https=) |